GlassScriptPhysician profile
Nicole M Cataldi
NPI 1013168343
$2,269.44
in general payments reported to CMS, 2019-2025
21 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $90.41 · 2021: $43.97 · 2022: $40.04 · 2023: $922 · 2024: $612 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.40 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $237.17 | 2021-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $224.68 | 2019-2024 | Acessa Provu System, Aptima |
| Pfizer INC. | $188.25 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $172.54 | 2023-2025 | |
| Exeltis, USA INC. | $147.30 | 2019-2024 | Slynd |
| Organon LLC | $146.61 | 2023-2025 | Nexplanon, Jada System |
| Shield Therapeutics INC | $121.97 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $92.98 | 2019-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Exact Sciences Corporation | $91.47 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $81.33 | 2020-2023 | Balcoltra |
| Millicent US INC | $79.99 | 2024-2025 | Intrarosa, Femring |
| Amag Pharmaceuticals, INC. | $70.08 | 2019-2020 | |
| Therapeuticsmd, INC. | $59.24 | 2019 | |
| Allergan, INC. | $55.67 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $49.41 | 2023-2024 | Twirla |
| Alydia Health | $31.94 | 2021 | |
| Mission Pharmacal Company | $28.26 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.22 | 2019 | |
| Sumitomo Pharma America, INC. | $21.37 | 2023 | Myfembree |
| Minerva Surgical, INC | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Cataldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.